Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KYNTRA BIO, INC.
Report date September 07, 2021 · Filed September 10, 2021
Section 16 reporting ended · disclosed 2021-09-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 274,536 |
Reported balance
After 2021-09-07 transaction · row 1
1 source rowRow 1 · 2021-09-07 · Tax withholding · Disposed 2,141 · Balance 274,536 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2017 Filed Jun 14, 2017 23:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,891 | $28.75 | $83,116.25 |
DisclosureSEC source: 0001209191-17-039952 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 23:49 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,151 | $29.05 | $33,436.55 |
DisclosureSEC source: 0001209191-17-038676 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,257 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 23:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,918 | $27.60 | $52,936.80 |
DisclosureSEC source: 0001209191-17-036939 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,408 F2 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 23:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-036939 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,357 Underlying: Common Stock · 10,000 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 23:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 10,000 | $2.90 | $29,000.00 |
DisclosureSEC source: 0001209191-17-036939 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,421 shares purchased through the issuer's employee stock purchase plan on May 15, 2017. Read SEC document |
| April 25, 2017 Filed Apr 28, 2017 00:44 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-028529 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 6,500 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 25, 2017 Filed Apr 28, 2017 00:44 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,500 | $28.00 | $182,000.00 |
DisclosureSEC source: 0001209191-17-028529 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,905 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| April 25, 2017 Filed Apr 28, 2017 00:44 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 6,500 | $2.35 | $15,275.00 |
DisclosureSEC source: 0001209191-17-028529 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:43 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 7,851 | $25.30 | $198,630.30 |
DisclosureSEC source: 0001209191-17-020662 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,905 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 01:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-17-019465 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2027-03-08 F3 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 01:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 38,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019465 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,756 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 06, 2017 Filed Mar 9, 2017 01:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,727 | $25.35 | $119,829.45 |
DisclosureSEC source: 0001209191-17-019465 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,521 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,600 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 5,600 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,600 | $26.00 | $145,600.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,248 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,600 | $2.35 | $13,160.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 900 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 900 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 01, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 900 | $26.00 | $23,400.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,248 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2017 Filed Mar 6, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 900 | $2.35 | $2,115.00 |
DisclosureSEC source: 0001209191-17-018468 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 22:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-003733 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 6,500 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 22:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,500 | $24.00 | $156,000.00 |
DisclosureSEC source: 0001209191-17-003733 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,248 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 22:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 6,500 | $2.35 | $15,275.00 |
DisclosureSEC source: 0001209191-17-003733 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 01:01 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,344 | $22.05 | $51,685.20 |
DisclosureSEC source: 0001209191-16-155264 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,248 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 01:42 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,410 | $20.55 | $28,975.50 |
DisclosureSEC source: 0001209191-16-153184 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,592 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 01:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,643 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-16-148767 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,357 Underlying: Common Stock · 1,643 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 01:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 1,643 | $2.90 | $4,764.70 |
DisclosureSEC source: 0001209191-16-148767 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 22:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,345 | $18.22 | $42,725.90 |
DisclosureSEC source: 0001209191-16-141466 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,359 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 14, 2015 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,334 F3 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2019, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.